{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:03:39Z","timestamp":1778864619780,"version":"3.51.4"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To assess the long-term efficacy and safety of treatments for cystoid macular edema in birdshot retinochoro\u00efditis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Observational retrospective study of 142 HLA-A29-positive patients with cystoid macular edema; the main outcome was the optical coherence tomography intraretinal cysts resolution.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>During the mean follow-up of 75 months (12\u2013178), 61.3% of patients were successfully treated using 1 to 3 treatment steps, while the others needed more steps. At 6 months, there were no significant effects on ME for anti-TNF (tumor necrosis factor) and IVIg (immunoglobulin) in contrast to antimetabolites (OR 1.98), systemic GCS (glucocorticosteroids), CsA (cyclosporine A) and tocilizumab (odds ratio closed to 2.7), intraocular injected GCS (odds ratio of 4.2), and interferon (odds ratio of 4.4). The percentages of therapeutic success trend to decrease from the initial three treatment steps to the subsequent treatment steps, for systemic GCS (84% to 70%), for anti-TNF (42% to 33%), and for CsA (71% to 33%); the success percentages did not decrease for injected GCS (83% to 89%). Macular edema recurrence occurred with the highest percentage for injected GCS (86.8%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.01) and the lowest for tocilizumab (10.5%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.001). Interferons-\u03b1 and tocilizumab were associated with the lowest prednisone daily doses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The classical uveitic cystoid macular edema therapeutic algorithm could be adapted to birdshot retinochoro\u00efditis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000004177","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T21:11:51Z","timestamp":1718313111000},"page":"1814-1822","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["CYSTOID MACULAR EDEMA IN BIRDSHOT RETINOCHORO\u00cfDITIS"],"prefix":"10.1097","volume":"44","author":[{"given":"Christine","family":"Fardeau","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Reference Center for Rare Diseases, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Paris-Sorbonne University, Paris, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gautier","family":"Breville","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Immunology and Allergy, Geneva University Hospitals, Geneva, Switzerland;"},{"name":"Department of Neurosciences, Division of Neurology, Geneva University Hospitals and Geneva University, Faculty of Medicine, Geneva, Switzerland;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud-Louis","family":"Jeannerot","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Reference Center for Rare Diseases, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Paris-Sorbonne University, Paris, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Herrmann","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation and Geriatrics, Division of Geriatrics, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meriem","family":"Touati","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Reference Center for Rare Diseases, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Paris-Sorbonne University, Paris, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Bonnin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Reference Center for Rare Diseases, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Paris-Sorbonne University, Paris, France;"},{"name":"Department of Ophthalmology, Fondation Rothschild, Universit\u00e9 de Paris, Paris, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Sales de Gauzy","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Reference Center for Rare Diseases, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Paris-Sorbonne University, Paris, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayria","family":"Sadegh","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Reference Center for Rare Diseases, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Paris-Sorbonne University, Paris, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira","family":"Toumi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Reference Center for Rare Diseases, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Paris-Sorbonne University, Paris, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Baglivo","sequence":"additional","affiliation":[{"name":"Clinique de l\u2019\u0152il Gen\u00e8ve and Swissvisio Gen\u00e8ve, Gen\u00e8ve, Switzerland;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Lariboisi\u00e8re Hospital, Paris-Sorbonne University, Paris, France; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Karmochkine","sequence":"additional","affiliation":[{"name":"Immunology Department, H\u00f4tel Dieu Hospital, Paris-Sorbonne University, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BAHRAM","family":"Bodaghi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Reference Center for Rare Diseases, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Paris-Sorbonne University, Paris, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg D.","family":"Seebach","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Immunology and Allergy, Geneva University Hospitals, Geneva, Switzerland;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PHUC","family":"Le Hoang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Reference Center for Rare Diseases, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Paris-Sorbonne University, Paris, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250605","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0002-9394(80)90226-3","article-title":"Birdshot retinochoroidopathy","volume":"89","author":"Ryan","year":"1980","journal-title":"Am J Ophthalmol"},{"key":"R2-20250605","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.survophthal.2005.08.004","article-title":"Birdshot chorioretinopathy","volume":"50","author":"Shah","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"R3-20250605","first-page":"350","article-title":"Birdshot retinochoroidopathy","volume":"9","author":"Vitale","year":"2014","journal-title":"J Ophthalmic Vis Res"},{"key":"R4-20250605","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jamaophthalmol.2013.6235","article-title":"Long-term clinical and anatomic outcome of birdshot chorioretinopathy","volume":"132","author":"Tomkins-Netzer","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"R5-20250605","doi-asserted-by":"crossref","first-page":"e0210799","DOI":"10.1371\/journal.pone.0210799","article-title":"Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis","volume":"14","author":"Matas","year":"2019","journal-title":"PLoS One"},{"key":"R6-20250605","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajo.2007.08.039","article-title":"Loss of visual field among patients with birdshot chorioretinopathy","volume":"145","author":"Thorne","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R7-20250605","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ophtha.2020.08.035","article-title":"Seven-year outcomes of uveitic macular edema: the multicenter uveitis steroid treatment trial and follow-up study results","volume":"128","author":"Tomkins-Netzer","year":"2021","journal-title":"Ophthalmology"},{"key":"R8-20250605","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ajo.2017.03.001","article-title":"Interferon-alpha2a and systemic corticosteroid in monotherapy in chronic uveitis: results of the randomized controlled BIRDFERON study","volume":"177","author":"Fardeau","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"R9-20250605","doi-asserted-by":"crossref","first-page":"142","DOI":"10.55563\/clinexprheumatol\/imrgo2","article-title":"Intravenous methylprednisolone induces rapid improvement in non-infectious uveitis: a multicentre study of 112 patients","volume":"40","author":"Vegas-Revenga","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"R10-20250605","first-page":"Cd010469","article-title":"Corticosteroid implants for chronic non-infectious uveitis","volume":"2","author":"Brady","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R11-20250605","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.survophthal.2021.12.002","article-title":"Efficacy and safety of intravitreal and periocular injection of corticosteroids in noninfectious uveitis: a systematic review","volume":"67","author":"Jos\u00e9-Vieira","year":"2022","journal-title":"Surv Ophthalmol"},{"key":"R12-20250605","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2017.5103","article-title":"Association between long-lasting intravitreous fluocinolone acetonide implant vs systemic anti-inflammatory therapy and visual acuity at 7 Years among patients with intermediate, posterior, or panuveitis","volume":"317","author":"Kempen","year":"2017","journal-title":"JAMA"},{"key":"R13-20250605","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/IAE.0b013e3181ff0d8f","article-title":"Efficacy of low-dose methotrexate treatment in birdshot chorioretinopathy","volume":"31","author":"Rothova","year":"2011","journal-title":"Retina"},{"key":"R14-20250605","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/bjophthalmol-2012-302123","article-title":"Combined therapy of cyclosporine A and mycophenolate mofetil for the treatment of birdshot retinochoroidopathy: a 12-month follow-up","volume":"97","author":"Cervantes-Casta\u00f1eda","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"R15-20250605","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/eye.2016.115","article-title":"Uveitic macular edema","volume":"30","author":"Fardeau","year":"2016","journal-title":"Eye (Lond)."},{"key":"R16-20250605","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2147\/OPTH.S180580","article-title":"Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges","volume":"13","author":"Massa","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"R17-20250605","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2147\/DDDT.S166092","article-title":"Update in treatment of uveitic macular edema","volume":"13","author":"Koronis","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"R18-20250605","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s10792-017-0592-5","article-title":"Adalimumab in refractory cystoid macular edema associated with birdshot chorioretinopathy","volume":"38","author":"Steeples","year":"2018","journal-title":"Int Ophthalmol"},{"key":"R19-20250605","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ajo.2018.12.019","article-title":"Anti-IL6-Receptor tocilizumab in refractory and noninfectious uveitic cystoid macular edema: multicenter study of 25 patients","volume":"200","author":"Vegas-Revenga","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"R20-20250605","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ophtha.2021.11.013","article-title":"Anti-tumor necrosis factor \u03b1 versus tocilizumab in the treatment of refractory uveitic macular edema: a multicenter study from the French uveitis network","volume":"129","author":"Leclercq","year":"2022","journal-title":"Ophthalmology"},{"key":"R21-20250605","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1076\/0927-3948(200003)811-SFT049","article-title":"Intravenous immunoglobulin (IVIg) for the treatment of birdshot retinochoroidopathy","volume":"8","author":"LeHoang","year":"2000","journal-title":"Ocul Immunol Inflamm"},{"key":"R22-20250605","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ajo.2013.05.002","article-title":"Interferon versus methotrexate in intermediate uveitis with macular edema: results of a randomized controlled clinical trial","volume":"156","author":"Mackensen","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"R23-20250605","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/bjophthalmol-2014-305535","article-title":"Mycophenolic acid in the treatment of birdshot chorioretinopathy: long-term follow-up","volume":"99","author":"Doycheva","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"R24-20250605","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1509852","article-title":"Adalimumab in patients with active noninfectious uveitis","volume":"375","author":"Jaffe","year":"2016","journal-title":"N Engl J Med"},{"key":"R25-20250605","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1080\/09273948.2020.1757123","article-title":"Efficacy of adalimumab in non-infectious uveitis across different etiologies: a post hoc analysis of the VISUAL I and VISUAL II trials","volume":"29","author":"Merrill","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"R26-20250605","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1097\/IAE.0000000000002281","article-title":"Adalimumab therapy for refractory birdshot chorioretinopathy","volume":"39","author":"Huis Het Veld","year":"2019","journal-title":"Retina"},{"key":"R27-20250605","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/eye.2012.10","article-title":"Histological findings of birdshot chorioretinopathy in an eye with ciliochoroidal melanoma","volume":"26","author":"Pulido","year":"2012","journal-title":"Eye (Lond)."},{"key":"R28-20250605","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/bjophthalmol-2020-317372","article-title":"Evaluation of fluocinolone acetonide 0.19 mg intravitreal implant in the management of birdshot retinochoroiditis","volume":"106","author":"Ajamil-Rodanes","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"R29-20250605","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1038\/s41433-021-01829-y","article-title":"Ciclosporin A in bilateral auto-immune chronic posterior uveitis associated with macular oedema: a long-term observational safety and efficacy study","volume":"36","author":"Alafaleq","year":"2022","journal-title":"Eye (Lond)"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T17:03:18Z","timestamp":1749142998000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004177"}},"subtitle":["Long-Term Treatment Study in 142 Patients"],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004177","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}